Top Biomed Stock Signal: AKRO
Report Date: 05-07-2022
Symbol: AKRO - Akero Therapeutics, Inc.
Sector:
Industry:
Top Biomed Stock Signal: AKRO
Akero Therapeutics, Inc. (AKRO)
170 Harbor Way
South San Francisco, CALIFORNIA 94080
Phone: 16504876488
Website: http://www.akerotx.com
CEO: Dr. Andrew Cheng
NASDAQ, Nasdaq Global Select
Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.